[SLN] QoQ Quarter Result on 30-Sep-2016 [#Q3]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
29-Sep-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- 21.67%
YoY- -48.08%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 8 8 385 385 0 0 0 -
PBT -3,328 -3,328 -2,410 -2,410 -2,771 -2,771 -2,644 16.59%
Tax 570 570 557 557 405 405 1,392 -44.88%
NP -2,758 -2,758 -1,854 -1,854 -2,367 -2,367 -1,252 69.38%
Tax Rate - - - - - - - -
Total Cost 2,766 2,766 2,239 2,239 2,367 2,367 1,252 69.71%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin -34,475.00 -34,475.00 -481.43 -481.43 0.00 0.00 0.00 -
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
EPS -0.12 -0.12 -0.08 -0.08 -0.10 -0.10 -0.05 79.35%
EPS Diluted -0.12 -0.12 -0.08 -0.08 -0.10 -0.10 -0.05 79.35%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.